Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 23, 2018
ABEC announced its manufacturing facility in Ireland has received certification from China as a qualified manufacturer of pressure vessels and components for use in China.
read more
Tuesday, February 13, 2018
ABEC announced the completion of its second ISO-7 cleanroom for single-use disposable container (DC) manufacturing.
read more
Tuesday, December 19, 2017
ABEC announced its manufacturing facility in Kells, Co. Meath, Ireland has received ASME Certificate of Authorization to manufacture and service pressure vessels.
read more
ABEC announced large-scale single-use microbial fermentation capability. ABEC’s CSR technology has demonstrated state-of-the-art performance with working volumes up to 1,000 liters.
read more
Wednesday, September 11, 2019
ABEC has introduced the Flexible Manufacturing Platform, a fully-customizable cell culture platform for flexible, high-volume biopharmaceutical production.
read more
Monday, September 25, 2017
Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory.
read more
Thursday, September 27, 2018
ABL announces the hire of Jarlath Keating as Chief Commercial Officer (CCO).
read more
ABL, a global contract research and manufacturing service provider to the U.S. Government and biopharmaceutical industry, has been awarded a five-year, indefinite delivery/indefinite quantity (ID/IQ) contract #HHSO100201600019I entitled “Respiratory ...
read more
Wednesday, October 16, 2019
ABL announced the company was awarded an IDIQ contract by the NCI of the NIH under its PREVENT Cancer Preclinical Drug Development Program.
read more
Advanced BioScience Laboratories announced it has been awarded a contract for "Preclinical and translational vaccine development for HIV and other candidate agents" by the Division of AIDS (DAIDS) within the National Institute of Allergy and ...
read more
Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.
read more
Tuesday, October 09, 2018
The license grants Memorial Sloan Kettering rights to research, develop and commercialize, with rights to sub-license, certain AlivaMab antibodies against a specific target.
read more
Wednesday, October 24, 2018
The non-exclusive license grants Voyager rights to use the AlivaMab Mouse for antibody drug discovery and development.
read more
Ablexis has announced the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company.
read more
Ablynx has entered into a research collaboration and global exclusive licensing agreement with Sanofi initially focused on developing and commercializing Nanobody-based therapeutics.
read more